Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 6.
Published in final edited form as: J Phys Chem B. 2021 Dec 9;125(50):13710–13717. doi: 10.1021/acs.jpcb.1c07762

A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in Tissue

Felix Gorka a,b, Sam Daly a, Colin M Pearson c, Edita Bulovaite d,e, Yu P Zhang a, Anoushka Handa a, Seth G N Grant d,e, Thomas N Snaddon c,*, Lisa-Maria Needham a,f,*, Steven F Lee a,*
PMCID: PMC7615715  EMSID: EMS194355  PMID: 34883017

Abstract

Optical imaging of protein aggregates in living and post-mortem tissue can often be impeded by unwanted fluorescence, prompting the need for novel methods to extract meaningful signal in complex biological environments. Historically, benzothiazolium derivatives, prominently Thioflavin T, have been the state-of-the-art fluorescent probes for amyloid aggregates, but their optical, structural, and binding properties typically limit them to in vitro applications. This study compares the use of novel uncharged derivative, PAP_1, with parent Thioflavin T as a fluorescence lifetime imaging probe. This is applied specifically to imaging recombinant α-synuclein aggregates doped into brain tissue. Despite the 100-fold lower brightness of PAP_1 compared to Thioflavin T, PAP_1 binds to α-synuclein aggregates with an affinity several orders of magnitude greater than Thioflavin T, thus we observe a specific decrease in the fluorescence lifetime of PAP_1 bound to α-synuclein aggregates resulting in a separation of >1.4 standard-deviations between PAP_1-stained brain tissue background and α-synuclein aggregates that is not observed with Thioflavin T. This enables contrast between high fluorescent background tissue and amyloid fibrils that is attributed to the greater affinity of PAP_1 for α-synuclein aggregates, avoiding the substantial off-target staining observed with Thioflavin T.

Introduction

The self-association of soluble peptides into insoluble proteinaceous accumulations in the intra- and extra-cellular space of the human brain is a common physical phenomenon among neurodegenerative diseases.1 The detection and characterisation of these amyloidogenic protein aggregates is vital for understanding the molecular mechanisms that underlie disease pathology. Fluorescence microscopy techniques are highly suited to the study of amyloid proteins, enabling kinetic and structural characterisation of aggregates by utilising the photophysical and binding properties of the existing palette of amyloid dyes.2 Among these is the N-methyl benzothiazolium dye Thioflavin T (ThT), which has become a gold-standard for studying amyloid aggregation in vitro due to its large turn-on fluorescence response upon binding (~1000 fold).3,4 This phenomenon is generally explained by the molecular rotor model, resulting from competition between radiative decay of the photo-excited state and a fast non-radiative deactivation channel linked to a dihedral twist between the aromatic subunits. The latter is suppressed when bound to amyloid aggregates culminating in a large increase in fluorescence quantum yield (ΦFl) and fluorescence lifetime (τFl).5,6 However, ThT binds amyloid with comparatively low affinity (μM) and its positive charge prevents blood-brain barrier permeability, rendering it unsuitable for most in vivo applications.7 Uncharged derivatives of ThT do not exhibit molecular rotor behaviour due to the lack of a positive charge on benzothiazole nitrogen. Instead, they behave as highly emissive fluorophores in polar solvents, but are prone to aggregation in aqueous media.8,9 Despite uncharged derivatives lacking the same magnitude of turn-on fluorescence upon amyloid binding exhibited by ThT; their higher affinity (nM) and ability to cross the blood-brain barrier render them useful amyloid probes.10

Currently, clinical amyloid imaging, for instance in diagnosis of Alzheimer’s disease, is mostly based on radiological methods like positron emission tomography (PET). Pittsburgh compound B,11 a neutral derivative of ThT radiolabelled with, for instance, 11C, has been widely used as a PET-marker for amyloid β (Aβ) and motivated further engineering of the neutral ThT scaffold to this purpose.12 Optical in vivo imaging, on the other hand, is still in its early stages of development, but shows potential to aid in understanding the underlying protein aggregation process due to its higher spatial resolution and multiple signal parameters sensitive to the microenvironment of the dye.3 However, fluorescence imaging of in vivo and post mortem brain tissue can be impeded by spatially heterogeneous background autofluorescence caused by a variety of reasons including emission of unbound or off-target bound dye and endogenous fluorophores,13 which is exacerbated in aged subjects.14 A variety of approaches have been reported in the literature to address this issue including; histochemical quenching,1518 photobleaching,19 background subtraction,20,21 near-infrared dyes7,2225 and fluorescence lifetime imaging microscopy (FLIM).13 FLIM is highly suited to the study of amyloid and can be used to exploit the sensitive response of the excited-state dynamics of amyloid probes to changes in their local environment. Post-processing techniques based on τFl data and amyloid probes with a τFl significantly different from the autofluorescence background have been applied to extract the desired signal.13 The near-infrared Aβ-probe CRANAD-3 has been used for in vivo imaging and separated from shorter-lived autofluorescence by its ~1.6 ns τFl in a fit-free unmixing-approach.24 Furthermore, a pyridophenazine ruthenium(II) complex exhibited a 185 ns photoluminescence lifetime upon binding to Aβ and was able to be distinguished from short-τFl artificially introduced background by use of a time-gating method.26

While a variety of extrinsic probes with potential for in vivo detection of aggregates have been developed,2730 new strategies that prioritise the detection of small, heterogeneous oligomeric species are of particular interest to the amyloid community,31 one approach to generate better contrast is to mitigate unwanted the background of complex sample environments. In this work we compare the performance of ThT and a recently reported novel derivative PAP_19 as τFl probes of amyloid. By specifically using the τFl information, i.e. the arrival time of single photons rather than the total number of photons, we were able to increase contrast in images of recombinant fibrils of α-synuclein (αSyn), the protein associated with Parkinson’s disease, artificially doped into autofluorescent brain tissue environments. In this imaging mode the contrast was achieved via a reduction in mean τFl of αSyn-bound PAP_1 compared to tissue autofluorescence and non-specifically tissue bound PAP_1. Furthermore, we were able to capitalize on the higher affinity of PAP_1 for αSyn aggregates compared to ThT, as well as an apparent homogenizing effect on the spatial distribution of the background in the τFl domain. These properties combined enabled the detection of αSyn fibrils by a larger contrast in τFl than would be possible with the conventional ThT probe.

Materials and Methods

Preparation of mouse brain samples

Tissue samples were prepared from either WT (HFB) or heterozygous PSD95-mEos2 (vHFB) mice expressing the mEos2 protein fused to the endogenous PSD95 protein according to a published procedure.32

Preparation of αSyn aggregates

Monomeric wild-type αSyn was purified from Escherichia coli according to a literature protocol33 and diluted into filtered (0.2 μm syringe filter, Whatman, 6780-1302) PBS buffer with 0.01% NaN3 to a concentration of 70 μM. Mature αSyn aggregates were obtained by incubating the monomer solution for >96 hours in the dark at 37 °C under constant shaking at 200 rpm.

Sonicated aggregates of αSyn were produced with pulse sonication using a tip sonicator (QSonica, Q125, tip size 1/8 inch). Each pulse consisted of a 5 second on state and a 15 second off state over 3 cycles at 40% power.

Preparation of fluorophores

Stock solutions of PAP_1 and ThT (AnaSpec, AS-88306) were prepared by completely dissolving the solid into dimethyl sulfoxide (DMSO, Sigma Aldrich, 276855) to a concentration of 10 mM. To ensure PAP_1 was completely solubilized in DMSO, it was sonicated for 10 minutes. These were stored in the dark at -80 °C. The stock solutions were diluted into filtered (0.02 μm syringe filter, Whatman, 6809-1102) PBS (pH 7.4) to the required concentration for experiments. The diluted dye solutions were then sonicated and filtered (0.02 μm syringe filter, Whatman, 6809-1102). The diluted solutions were stored in the dark at 4 °C for a maximum of a week after preparation.2 Reasonable academic requests for PAP_1 should be sent directly to sl591@cam.ac.uk, where upon will be happy to share.

Solutions of anti-aSyn antibody (211) labelled with Alexa Fluor 647 (Syn211-AF647) (sc12767, Santa Cruz Biotechnology) were prepared in filtered (0.02 μm syringe filter, Whatman, 6809-1102) PBS (pH 7.4) to a concentration of 70 μM and were stored in the dark at –20 °C. The stock solutions were diluted into filtered PBS to 100 nM for experiments.

Slide preparation for FLIM

Glass coverslips were cleaned with an argon plasma (ODC-002, Harrick Plasma) for one hour. On the coverslip, a ~1 cm2 area was encircled with a hydrophobic barrier pen, incubated with poly-L-lysine (PLL, 70 μL, 0.1% w/v, Sigma Aldrich, P820) for 30 minutes, the excess liquid removed, and the surface washed with filtered PBS. An aliquot of the αSyn aggregation solution was diluted to an equivalent of 5 μM monomer concentration, of which 50 μL were deposited on the PLL surface, incubated for 3 minutes, and then aspirated to ensure good adherence to the PLL coated surface. The excess liquid was removed, the surface washed with PBS again and 20 μL of either PAP_1 (50 μM), ThT (5 μM) in PBS added. ThT experiments were performed at a 10-fold reduced concentration compared to PAP_1 to account for both the greater brightness and lower αSyn binding affinity of ThT relative to PAP_1. For the measurements with both HFB and vHFB brain tissue, sectioned mouse brain tissue slices on glass coverslips were thawed to room temperature and gently washed with PBS, and a ~1 cm2 area surrounding the tissue was encircled with a hydrophobic barrier pen. PLL was incubated on the brain tissue for 10 minutes, the excess liquid removed and washed gently with PBS. αSyn aggregates (5 μM) or sonicated αSyn aggregates (50 nM) were deposited onto the PLL, incubated for 3 minutes, then gently aspirated. The excess liquid was removed, the surface washed with PBS again and 20 μL of either PAP_1 (50 μM), ThT (5 μM), or Syn211-AF647 (100 nM) in PBS were added. An argon cleaned glass coverslip was placed on top and imaged immediately (Figure S4).

FLIM data acquisition

FLIM was performed on a MicroTime 200 confocal microscope (PicoQuant) using time correlated single photon counting (TCSPC). A 407 nm ps-pulsed diode laser at 40 MHz repetition rate was used as excitation source. The excitation beam was focused through a microscope objective lens (60 ×, UPlanSApo, NA 1.2, water-immersion, Olympus) onto the sample. The laser power was attenuated by a neutral density filter to a pulse energy of 250 fJ and average power of 1 μW at the objective to avoid sample degradation. Single point measurements without tissue were performed at tenfold radiant power. Emission light was collected through the same objective, separated with a dichroic mirror (ZT405rdc, Chroma) and passed through a 30 μm pinhole and either a 425 nm (PAP_1), 488 nm (ThT) or 640 nm (AF647) dielectric long pass filter (Chroma) onto the single-photon avalanche diode detector. Photon arrival times were recorded and histogrammed with 16 ps bin width. The instrument response function was measured experimentally from the KI-quenched fluorescence decay of fluorescein in basic ethanol to be of approximately gaussian shape with ~130 ps FWHM.

Analysis of τFl decays

Least squares fitting of the τFl images was performed in SymPhoTime software. At first, the sum of all pixels was fitted with a double exponential tail-fit starting ~0.8 ns after the leading edge of the laser pulse to get the two major τFl contributions. After that, a pixel-by-pixel fit was performed with fixed τFl to recover their respective amplitudes in each pixel. The average τFl was obtained by intensity weighting of the respective τFl components τ1 and τ2 with amplitudes α1 and α2.34

τFl=α1τ12+α2τ22α1τ1+α2τ2

Pixels with less than 50 counts were omitted for subsequent statistical analyses. Fluorescence lifetime histograms were generated from the image pixels with 0.0625 ns bin width.

Results and Discussion

We introduce neutral derivative of ThT, PAP_1 (Figure 1A, Figure S1A), as a τFl imaging probe. PAP_1 is a small, weakly-fluorescent molecule that binds to mature αSyn fibrils with several orders of magnitude higher association constant than ThT (Figure S1B) and responds optically with a modest increase in fluorescence intensity (Figure 1B).9 Despite the more practically complex photophysical properties of PAP_1 compared to ThT, its relatively higher binding affinity for αSyn enabled amyloid detection in both the bulk and single-aggregate regimes. Initially we characterised the τFl contrast obtained by PAP_1 in response to αSyn fibril binding in a low fluorescence background (LFB) environment (phosphate buffered saline, PBS). FLIM images of PAP_1 bound to mature recombinant αSyn fibrils adhered to a poly-L-lysine (PLL) coated surface, were readily visualized (Figure 1C) and single-point τFl decay curves of PAP_1 were measured (Figure 1D). The fluorescence decay of αSyn fibril-bound PAP_1 was faster than the PLL control with 0.5 ns and 1.1 ns (FWHM) respectively. Bi-exponential tail-fits yielded a relatively large change in the mean τFl of 1.51 ± 0.07 ns (for αSyn fibril-bound PAP_1) and 1.93 ± 0.06 ns for the control (PAP_1 in the absence of fibrils), a 28% reduction in τFl. The low χ2-values and weighted residuals (Figure S2B) suggest that the fluorescence decay after ~0.8 ns of both free and αSyn bound PAP_1 is well described by the bi-exponential model. FLIM confirmed that the 1.51 ns mean τFl of αSyn fibril-bound PAP_1 remains uniform on the aggregate surface (Figure 1C). The magnitude of the change in measured τFl of αSyn bound PAP_1 relative to PAP_1 in PBS does not correspond to the change in ΦFl, which highlights both the complexity associated with quantifying physical properties of heterogeneous systems and the importance of spatially resolved, high-resolution measurements. Single-point decay curves of ThT on a PLL surface showed decays faster than the instrument response function thus could not be fit, however FLIM measurements (Figure S3B) and single-point decay curves of ThT bound to αSyn fibrils exhibited an increase in mean τFl to 2.12 ± 0.1 ns (Figure S3C). Despite undergoing an increase in fluorescence intensity upon αSyn fibril incorporation, the τFl of PAP_1 decreased upon binding, contrary to ThT. The origin of this is not yet understood, however it is known that the mechanism of fluorescence intensity increase upon binding differs between the two dyes. Whilst the fluorogenicity of ThT evolves from restriction of conformational freedom, a decrease in the aggregation state of the PAP_1 in the more hydrophobic protein environment likely drives the fluorescence increase (Figure S1C). Our previous work has shown that fitting fluorescence decays by iterative reconvolution and a stretched exponential decay law models the change in τFl upon binding well in single-point measurements.9 However, this method was found too flexible and unreliable when fitting single pixels with lower photon counts in imaging experiments. Instead, tail-fitting with a bi-exponential model is utilized and decay time amplitudes are fitted in each pixel (Materials and Methods). The decrease in PAP_1 τFl upon binding was captured by both models.

Figure 1.

Figure 1

A) Molecular structures of PAP_1 and ThT and a schematic showing PAP_1-stained recombinant aggregates of αSyn immobilised on a low fluorescence background (LFB) PLL surface. Excitation is achieved in a confocal geometry with fluorescence photons being collected by the same objective, focussed through a pinhole and onto a single-photon sensitive photodiode. B) Normalized absorption and fluorescence emission spectra of PAP_1 in PBS buffer and bound to late-stage aggregates of α-Syn, reprinted from 9 with permission. C) Intensity and color-coded τFl FLIM measurements of PAP_1 stained αSyn fibrils. D) Comparison of fluorescence decay curves of PLL-control and αSyn bound PAP_1 from single-point measurements with elevated integration time. τFl values and errors were determined from a mean and standard-deviation of ≥ four single-point measurements with the same bi-exponential tail-fitting model used for image analysis.

We next investigated the feasibility of ThT and PAP_1 as τFl imaging probes for αSyn aggregates in tissue. We affixed αSyn fibrils onto thin sections of adult mouse brain tissue using PLL, which were subsequently stained with either ThT or PAP_1, to simulate a high fluorescence background (HFB) (Figure S4). The fitted τFl values obtained enable the relative contrast between HFB and αSyn to be determined. In the WT HFB samples, while some αSyn fibrils could be somewhat visually distinguished from background in the intensity domain for both dyes (Figure 2Ai-ii, Figure S5A, Figure S6A), this became increasingly difficult in regions of particularly intense tissue or off-target dye fluorescence. A mean τFl image with PAP_1, however, provided sharper contrast between stained αSyn fibrils (<2.9 ns) and tissue background (>3.4 ns), as the convoluted intensity features of the latter were homogenized in the τFl domain (Figure 2Bi, Figure S5B). The intrinsic ~28% decrease of PAP_1 in τFl upon binding aided this contrast, but its 1.51 ns average τFl was likely not obtained exactly due to mixing with tissue autofluorescence signal and poorer resolution of the decay curve at the given signal levels. The τFl measured is a complex convolution of the probe and the tissue environment, the τFl values should not be over-interpreted as an absolute quantification, the significance and utility arises purely from the relative contrast generated by it. Despite being able to visualize ThT stained αSyn fibrils in the intensity domain (Figure 2Aii, Figure S6A), a significantly weaker τFl contrast was observed (Figure 2Bii), with stained αSyn fibrils showing τFl of ~1.9 ns ns compared to background values of >1.9 ns as well as several instances of fibrils being undiscernible from background in the τFl domain (Figure S6B).

Figure 2.

Figure 2

Images showing Ai) fluorescence intensity and Bi) τFl of PAP_1 stained αSyn aggregates and Aii) fluorescence intensity and Bii) τFl of ThT stained αSyn aggregates both imaged in a WT HFB mouse brain tissue sample. Histograms comparing the pixel values αSyn aggregates and WT HFB stained with PAP_1 in the Ci) fluorescence intensity and Di) τFl domains and stained with ThT in the Cii) fluorescence intensity and Dii) τFl domains. Both the intensity and τFl contrast of PAP_1 and ThT stained images have been set independently.

Histograms of the image pixel values comparing both fluorescence intensity (Figure 2Ci-Cii) and τFl (Figure 2Di-Dii) of stained αSyn aggregates and WT HFB were generated by applying a threshold to the images. Detection of αSyn aggregates in HFB tissue with both ThT and PAP_1 was severely hindered by poor contrast in the intensity domain (Figure 2Ci-Cii). While the ThT staining yielded a mean τFl of 1.90 ± 0.09 ns at the αSyn aggregates compared to 1.97 ± 0.09 ns of WT HFB tissue and thus only minute τFl contrast, PAP_1 staining achieved greater separation with 2.85 ± 0.40 ns on αSyn aggregates and 3.46 ± 0.45 ns of WT HFB. Thus, τFl distributions of WT HFB background and αSyn bound PAP_1 were separated by >1.4 σ (Figure 2Ci), while ThT can only achieve a difference of 0.7 σ (Figure 2Cii). In addition, the τFl histograms overlapped by 45% with PAP_1 and 67% with ThT staining. Consequently, PAP_1 can generate a significantly stronger τFl contrast than parent ThT. Line profiles (Figure S7) showed spatial correlation between low-resolution intensity peaks and a >1.5 ns reduction in mean τFl at the fibril positions. This superior contrast was aided by the more spatially homogenous background pixel values of the τFl domain compared with the intensity domain.

The poor performance of ThT in the τFl domain is likely due to substantial off-target binding of the dye to tissue structures, which contributed to the HFB signal with a similar τFl as the fraction of ThT bound to αSyn. Simply put, the promiscuity of ThT for the numerous available binding sites in complex environments was larger than that of PAP_1. Despite the greater fluorescence contrast afforded by ThT in the intensity domain, the advantage was nullified by the poor specificity, preventing conclusive discrimination between amyloid aggregates and other bright structures (Figure S6A, Figure S7Aii).

In control experiments without αSyn aggregates, significantly smaller mean τFl were observed for ThT stained (1.92 ± 0.08 ns) than unstained tissue sections (3.47 ± 0.53 ns), showing that tissue fluorescence was dominated by ThT emission in this case (Figure S8-9). Perturbation of the tissue τFl by PAP_1 was found to be less pronounced (3.56 ± 0.64 ns). The significantly smaller dissociation constant of PAP_1 for αSyn aggregates was a clear advantage over ThT, whose off-target binding compromised the τFl contrast.

The application of extrinsic dyes to amyloid such as PAP_1 offer labelling simplicity, environmental sensitivity, and a route toward development of blood-brain barrier penetrable probes for in vivo imaging; however, antibodies provide target specificity in conjunction with access to a palette of bright fluorescent probes in desirable spectral regions. The ability to detect increasingly small amyloid aggregates in increasingly complex environments is a key challenge faced by the amyloid community.31 Thus, we compared the capabilities of PAP_1 (Figure S10) and traditional antibody staining using the anti-αSyn antibody (syn211-AF647, Figure S11) to detect sonicated fibrils of αSyn in HFB. Bright fluorescent puncta were observed in the fluorescence intensity domain with PAP_1 stained αSyn (S10Ai). This was correlated in the τFl domain (Figure S10Aii), and contrast was achieved in both imaging modes. However, pixel values of τFl were significantly more homogenous compared to values of photon intensity Figure S10B). Bright fluorescent puncta were also observed when staining sonicated αSyn fibrils with syn211-AF647 in HFB (Figure S11Ai) which also manifested τFl contrast (Figure S11Bi). However, the negative control, produced significant false positive fluorescent species, with similar contrast, when compared to directly to syn211-AF647 stained αSyn in HFB. These data suggest that antibody staining only cannot exclusively identify small αSyn aggregates (Figure S11Aii, Figure S11Ci-ii). The contrast achieved in the τFl domain of syn211-AF647 stained αSyn is greater than the control (Figure S11Di-ii), illustrating the promise of τFl based detection of aggregates in HFB.

Next, we endeavoured to increase the environmental complexity to explore whether the superior τFl based detection with PAP_1 compared to ThT translated into HFB samples with spatially heterogenous emission. We created tissue sections, from genetically modified mice, which expressed a fluorescent protein conjugated to postsynaptic density protein 95 (PSD95). PSD95 is a well-studied, highly expressed protein found distributed across neurons, and found concentrated in the protein density attached to the postsynaptic membrane.35 This generated an additional, spatially heterogeneous source of fluorescence to simulate a complex sample matrix, that impeded detection of αSyn aggregates by fluorescence microscopy and provided a challenging test environment to compare dye properties. For consistency, this sample will be referred to as varying-High Fluorescence Background (vHFB).

Tissue autofluorescence and non-specific dye binding impeded fluorescence intensity-based detection of αSyn aggregates with both ThT and PAP_1, as with WT HFB (Figure S12Ai-ii, Figure S13A, Figure S14A). Poor τFl contrast was observed with ThT stained αSyn fibrils in vHFB with a mean τFl of 1.84 ± 0.16 ns at the αSyn aggregates compared to 1.92 ± 0.13 ns of vHFB tissue. PAP_1 also demonstrated a greater τFl separation with 2.63 ± 0.44 ns on αSyn aggregates and 3.28 ± 0.27 ns of vHFB. The τFl distributions of stained αSyn aggregates and vHFB overlap by 79% for ThT and 34% for PAP_1 (Figure S12Di-ii). As with WT HFB, line profiles (Figure S15) displayed spatial overlap between intensity peaks and a ~1 ns reduction in mean τFl at the fibril positions in vHFB.

Conclusion

This work has explored the performance of ThT and related, uncharged chemical probe PAP_1 in τFl imaging of αSyn aggregates in a highly fluorescent background of brain tissue. PAP_1 exhibited excited-state kinetics which were well-approximated with bi-exponential decays and experienced a near 28% decrease in mean τFl upon binding to αSyn aggregates compared with its unbound state. Despite PAP_1 lacking the typical molecular rotor properties of ThT and its generally low brightness, it exhibited a significantly greater contrast in the τFl domain among the convolution of surrounding long-lived tissue fluorescence and non-specifically bound dye. Substantial off-target binding of ThT to tissue structures paired with high brightness compromised its τFl contrast, confirming the higher binding affinity of the uncharged ThT scaffold for αSyn aggregates as a key advantage for τFl imaging in tissue. Furthermore, τFl contrast was aided by the more spatially homogenous features of the tissue background in the τFl domain relative to the intensity domain. Based on these results, PAP_1 shows promise as a τFl probe for the detection of amyloid aggregates in highly fluorescent biological environments, where intensity contrast is difficult to achieve without quenching procedures that alter the sample.

Future work involving PAP_1 for endogenous aggregate detection in the post-mortem brain is key to secure its efficacy for this application, as the obtainable τFl contrast depends on the unwanted autofluorescence τFl. Coincident labelling with an antibody conjugated to a red fluorescent dye could, for instance, be used to confirm PAP_1’s target specificity. The promising initial results with this neutral dye provide a route towards potential alternative in vivo imaging with extrinsic amyloid dyes. The main limitation to the efficacy of PAP_1 as a τFl probe is its low brightness. Therefore, in addition, further engineering of the neutral ThT scaffold towards optimized emission properties and a τFl, that also allows for contrast against shorter lived autofluorescence, will improve its performance as a τFl probe in high autofluorescence environments such as cells and tissue, thus increasing the physiological relevance of fluorescence studies of amyloid and neurodegenerative diseases.

Supplementary Material

Supplementary figures

TOC Graphic.

TOC Graphic

Acknowledgements

We thank the Royal Society for the University Research Fellowship of S.F.L. (UF120277). This work was funded in-part by the Michael J. Fox Foundation and the National Institutes of Health under award number R01GM121573 (awarded to T.N.S.). We thank the EPSRC for the IAA Follow-on-fund (awarded to S.F.L.). We thank Ewa Klimont and Swapan Preet for α-synuclein protein expression and purification We thank the European Union’s Horizon 2020 research and innovation programme for the Marie Skłodowska-Curie fellowship awarded to L.-M.N. (agreement No 886216). Work in the Grant lab is funded by the Wellcome Trust (Technology Development grants 202932, 218293), the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme (695568 SYNNOVATE), and the Simons Foundation Autism Research Initiative (529085).

Footnotes

Author contributions

S. F. L., L.-M.N. and F.G. designed the experiments. C.M.P. and T. N. S. synthesized the PAP_1. E.B., A.H. and S.G.N.G. prepared and provided the mouse brain samples. F.G. performed low fluorescence background FLIM experiments. Y.Z. provided sonicated αSyn aggregates and the anti-αSyn 211 antibody. F.G., L. M. N. and S.D. performed high fluorescence background FLIM experiments. S.D. performed antibody imaging experiments. F.G. and L.M.N analyzed the data. F.G., S.D., L. M. N., and S. F. L. all co-wrote the manuscript.

References

  • (1).Chiti F, Dobson CM. Protein Misfolding, Functional Amyloid, and Human Disease. Annual Review of Biochemistry. 2006;75(1):333–366. doi: 10.1146/annurev.biochem.75.101304.123901. [DOI] [PubMed] [Google Scholar]
  • (2).Nilsson MR. Techniques to Study Amyloid Fibril Formation in Vitro. Methods. 2004;34(1):151–160. doi: 10.1016/j.ymeth.2004.03.012. [DOI] [PubMed] [Google Scholar]
  • (3).Bertoncini CW, Soledad Celej M. Small Molecule Fluorescent Probes for the Detection of Amyloid Self-Assembly In Vitro and In Vivo. Current Protein & Peptide Science. 2011;12(3):206–220. doi: 10.2174/138920311795860151. [DOI] [PubMed] [Google Scholar]
  • (4).Aliyan A, Cook NP, Martí AA. Interrogating Amyloid Aggregates Using Fluorescent Probes. Chemical Reviews. 2019;119:11819–11856. doi: 10.1021/acs.chemrev.9b00404. [DOI] [PubMed] [Google Scholar]
  • (5).Stsiapura VI, Maskevich AA, Kuzmitsky VA, Turoverov KK, Kuznetsova IM. Computational Study of Thioflavin T Torsional Relaxation in the Excited State. Journal of Physical Chemistry A. 2007;111(22):4829–4835. doi: 10.1021/jp070590o. [DOI] [PubMed] [Google Scholar]
  • (6).Stsiapura VI, Maskevich AA, Kuzmitsky VA, Uversky VN, Kuznetsova IM, Turoverov KK. Thioflavin T as a Molecular Rotor: Fluorescent Properties of Thioflavin T in Solvents with Different Viscosity. The Journal of Physical Chemistry B. 2008;112(49):15893–15902. doi: 10.1021/jp805822c. [DOI] [PubMed] [Google Scholar]
  • (7).Nesterov EE, Skoch J, Hyman BT, Klunk WE, Bacskai BJ, Swager TM. In Vivo Optical Imaging of Amyloid Aggregates in Brain: Design of Fluorescent Markers. Angewandte Chemie - International Edition. 2005;44(34):5452–5456. doi: 10.1002/anie.200500845. [DOI] [PubMed] [Google Scholar]
  • (8).Gogoleva SD, Kalganova EV, Maskevich AA, Lugovski AA, Kuzmitsky VA, Goswami M, Buganov OV, Tikhomirov SA, Stsiapura VI. Neutral Derivatives of Thioflavin T Do Not Exhibit Viscosity-Dependent Fluorescence. Journal of Photochemistry and Photobiology A: Chemistry. 2018;358:76–91. doi: 10.1016/j.jphotochem.2018.03.003. [DOI] [Google Scholar]
  • (9).Needham LM, Weber J, Pearson CM, Do DT, Gorka F, Lyu G, Bohndiek SE, Snaddon TN, Lee SF. A Comparative Photophysical Study of Structural Modifications of Thioflavin T-Inspired Fluorophores. The journal of physical chemistry letters. 2020;11(19):8406–8416. doi: 10.1021/acs.jpclett.0c01549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).Klunk WE, Wang Y, Huang G, Debnath ML, Holt DP, Mathis CA. Uncharged Thioflavin-T Derivatives Bind to Amyloid-Beta Protein with High Affinity and Readily Enter the Brain. Life Sciences. 2001;69(13):1471–1484. doi: 10.1016/S0024-3205(01)01232-2. [DOI] [PubMed] [Google Scholar]
  • (11).Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang G, Estrada S, et al. Imaging Brain Amyloid in Alzheimer’s Disease with Pittsburgh Compound-B. Annals of Neurology. 2004;55(3):306–319. doi: 10.1002/ana.20009. [DOI] [PubMed] [Google Scholar]
  • (12).Villemagne VL. Amyloid Imaging: Past, Present and Future Perspectives. Ageing Research Reviews. 2016;30:95–106. doi: 10.1016/j.arr.2016.01.005. [DOI] [PubMed] [Google Scholar]
  • (13).Jones PB, Rozkalne A, Meyer-Luehmann M, Spires-Jones TL, Makarova A, Kumar ATN, Berezovska O, Bacskai BB, Hyman BT. Two Postprocessing Techniques for the Elimination of Background Autofluorescence for Fluorescence Lifetime Imaging Microscopy. Journal of Biomedical Optics. 2008;13(1):014008. doi: 10.1117/1.2837169. [DOI] [PubMed] [Google Scholar]
  • (14).Tsuchida M, Miura T, Aibara K. Lipofuscin and Lipofuscin-like Substances. Chemistry and Physics of Lipids. 1987;44(2–4):297–325. doi: 10.1016/0009-3084(87)90055-7. [DOI] [PubMed] [Google Scholar]
  • (15).Barden H. The Presence of Ethylenic Bonds and Vic-Glycol Groups in Neuromelanin and Lipofuscin in the Human Brain. Journal of Histochemistry & Cytochemistry. 1983;31(7):849–858. doi: 10.1177/31.7.6854003. [DOI] [PubMed] [Google Scholar]
  • (16).Barden H. The Oxidative Generation of Sulfonic Acid Groups in Neuromelanin and Lipofuscin in the Human Brain. Journal of Histochemistry and Cytochemistry. 1984;32(3):329–336. doi: 10.1177/32.3.6198360. [DOI] [PubMed] [Google Scholar]
  • (17).Clancy B, Cauller LJ. Reduction of Background Autofluorescence in Brain Sections Following Immersion in Sodium Borohydride. Journal of Neuroscience Methods. 1998;83(2):97–102. doi: 10.1016/S0165-0270(98)00066-1. [DOI] [PubMed] [Google Scholar]
  • (18).Schnell SA, Staines WA, Wessendorf MW. Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue. Journal of Histochemistry and Cytochemistry. 1999;47(6):719–730. doi: 10.1177/002215549904700601. [DOI] [PubMed] [Google Scholar]
  • (19).Neumann M, Gabel D. Simple Method for Reduction of Autofluorescence in Fluorescence Microscopy. Journal of Histochemistry and Cytochemistry. 2002;50(3):437–439. doi: 10.1177/002215540205000315. [DOI] [PubMed] [Google Scholar]
  • (20).Steinkamp JA, Stewart CC. Dual-laser, Differential Fluorescence Correction Method for Reducing Cellular Background Autofluorescence. Cytometry. 1986;7(6):566–574. doi: 10.1002/cyto.990070611. [DOI] [PubMed] [Google Scholar]
  • (21).Van de Lest CHA, Versteeg EMM, Veerkamp JH, Van Kuppevelt TH. Elimination of Autofluorescence in Immunofluorescence Microscopy with Digital Image Processing. Journal of Histochemistry and Cytochemistry. 1995;43(7):727–730. doi: 10.1177/43.7.7608528. [DOI] [PubMed] [Google Scholar]
  • (22).Calvo-Rodriguez M, Hou SS, Snyder AC, Dujardin S, Shirani H, Nilsson KPR, Bacskai BJ. In Vivo Detection of Tau Fibrils and Amyloid β Aggregates with Luminescent Conjugated Oligothiophenes and Multiphoton Microscopy. Acta neuropathologica communications. 2019;7(1):171. doi: 10.1186/s40478-019-0832-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (23).Li YL, Cai J, Yan L, Zhang W, Li L, Du Z, Fang YX, Dong CZ, Meunier B, Chen H. Phenothiazine-Based Theranostic Compounds for in Vivo near-Infared Fluorescence Imaging of β-Amyloid Plaques and Inhibition of Aβ Aggregation. Dyes and Pigments. 2019 May;171:1–7. doi: 10.1016/j.dyepig.2019.107744. [DOI] [Google Scholar]
  • (24).Chen C, Liang Z, Zhou B, Li X, Lui C, Ip NY, Qu JY. In Vivo Near-Infrared Two-Photon Imaging of Amyloid Plaques in Deep Brain of Alzheimer’s Disease Mouse Model. ACS Chemical Neuroscience. 2018;9(12):3128–3136. doi: 10.1021/acschemneuro.8b00306. [DOI] [PubMed] [Google Scholar]
  • (25).Yan J, Zhu J, Zhou K, Wang J, Tan H, Xu Z, Chen S, Lu Y, Cui M, Zhang L. Neutral Merocyanine Dyes: For in Vivo NIR Fluorescence Imaging of Amyloid-β Plaques. Chemical Communications. 2017;53(71):9910–9913. doi: 10.1039/C7CC05056A. [DOI] [PubMed] [Google Scholar]
  • (26).Cook NP, Torres V, Jain D, Martí AA. Sensing Amyloid-β Aggregation Using Luminescent Dipyridophenazine Ruthenium(II) Complexes. Journal of the American Chemical Society. 2011;133(29):11121–11123. doi: 10.1021/ja204656r. [DOI] [PubMed] [Google Scholar]
  • (27).Gaur P, Galkin M, Kurochka A, Ghosh S, Yushchenko DA, Shvadchak Vv. Fluorescent Probe for Selective Imaging of α-Synuclein Fibrils in Living Cells. ACS Chemical Neuroscience. 2021;12(8):1293–1298. doi: 10.1021/ACSCHEMNEURO.1C00090/SUPPL_FILE/CN1C00090_SI_001.PDF. [DOI] [PubMed] [Google Scholar]
  • (28).McMurray L, MacDonald JA, Ramakrishnan NK, Zhao Y, Williamson DW, Tietz O, Zhou X, Kealey S, Fagan SG, Smolek T, et al. Synthesis and Assessment of Novel Probes for Imaging Tau Pathology in Transgenic Mouse and Rat Models. ACS Chemical Neuroscience. 2021;12(11):1885–1893. doi: 10.1021/ACSCHEMNEURO.0C00790/SUPPL_FILE/CN0C00790_SI_001.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (29).Watanabe H, Ono M, Ariyoshi T, Katayanagi R, Saji H. Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates. ACS Chemical Neuroscience. 2017;8(8):1656–1662. doi: 10.1021/ACSCHEMNEURO.6B00450/SUPPL_FILE/CN6B00450_SI_001.PDF. [DOI] [PubMed] [Google Scholar]
  • (30).Bertoncini CW, Soledad Celej M. Small Molecule Fluorescent Probes for the Detection of Amyloid Self-Assembly In Vitro and In Vivo. Current Protein & Peptide Science. 2011;12(3):206–220. doi: 10.2174/138920311795860151. [DOI] [PubMed] [Google Scholar]
  • (31).Chiti F, Dobson CM. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annual Review of Biochemistry. 2017;86(1):27–68. doi: 10.1146/annurev-biochem-061516-045115. [DOI] [PubMed] [Google Scholar]
  • (32).Broadhead MJ, Horrocks MH, Zhu F, Muresan L, Benavides-Piccione R, DeFelipe J, Fricker D, Kopanitsa MV, Duncan RR, Klenerman D, et al. PSD95 Nanoclusters Are Postsynaptic Building Blocks in Hippocampus Circuits. Scientific Reports. 2016;6:1–14. doi: 10.1038/srep24626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (33).Hoyer W, Antony T, Cherny D, Heim G, Jovin TM, Subramaniam V. Dependence of α-Synuclein Aggregate Morphology on Solution Conditions. Journal of Molecular Biology. 2002;322(2):383–393. doi: 10.1016/S0022-2836(02)00775-1. [DOI] [PubMed] [Google Scholar]
  • (34).Lakowicz JR. Principles of Fluorescence Spectroscopy. Principles of Fluorescence Spectroscopy. 2006:1–954. doi: 10.1007/978-0-387-46312-4. [DOI] [Google Scholar]
  • (35).Zhu F, Cizeron M, Qiu Z, Benavides-Piccione R, Kopanitsa MV, Skene NG, Koniaris B, DeFelipe J, Fransén E, Komiyama NH, et al. Architecture of the Mouse Brain Synaptome. Neuron. 2018;99(4):781–799.:e10. doi: 10.1016/j.neuron.2018.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary figures

RESOURCES